Balance Sheet
AssetsCash & Current InvestmentsCommon EquityCurrent Deferred RevenueGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPensionPreferred SharesProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredRetained EarningsSecurities - TradableShareholder's EquityShort-term InvestmentsTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Allstate (ALL-PB) Other Accumulated Expenses (2016 - 2025)

Allstate (ALL-PB) has disclosed Other Accumulated Expenses for 15 consecutive years, with $41.1 billion as the latest value for Q4 2025.

  • Quarterly Other Accumulated Expenses fell 2.0% to $41.1 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $41.1 billion through Dec 2025, down 2.0% year-over-year, with the annual reading at $41.1 billion for FY2025, 2.0% down from the prior year.
  • Other Accumulated Expenses for Q4 2025 was $41.1 billion at Allstate, down from $43.1 billion in the prior quarter.
  • The five-year high for Other Accumulated Expenses was $44.1 billion in Q2 2025, with the low at $31.4 billion in Q1 2021.
  • Average Other Accumulated Expenses over 5 years is $38.4 billion, with a median of $40.0 billion recorded in 2023.
  • The sharpest move saw Other Accumulated Expenses grew 19.74% in 2021, then fell 2.0% in 2025.
  • Over 5 years, Other Accumulated Expenses stood at $33.1 billion in 2021, then grew by 13.55% to $37.5 billion in 2022, then increased by 6.17% to $39.9 billion in 2023, then increased by 5.17% to $41.9 billion in 2024, then fell by 2.0% to $41.1 billion in 2025.
  • According to Business Quant data, Other Accumulated Expenses over the past three periods came in at $41.1 billion, $43.1 billion, and $44.1 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.